![David Cook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Cook
Chief Tech/Sci/R&D Officer at
FORMA THERAPEUTICS HOLDINGS, INC.
Profile
Dr. David N.
Cook is a Chief Scientific Officer & Senior Vice President at Forma Therapeutics Holdings, Inc. and a Chief Executive Officer & Director at Edgewood Oncology, Inc. He is on the Board of Directors at Novome Biotechnologies, Inc., Global HIV Vaccine Enterprise, Edgewood Oncology, Inc. and X-Biotix Therapeutics, Inc. Dr. Cook was previously employed as a Chief Scientific Officer & Executive VP-Research by Seres Therapeutics, Inc., a Chief Operating Officer by International AIDS Vaccine Initiative, Inc., a Head-Business Advocacy by Bio Ventures for Global Health, a Chief Executive Officer by Anza Therapeutics, Inc., a Senior Vice President-Research & Development by Cerus Corp., and a Senior Vice President-Research & Development by COULTER CELLULAR THERAPIES INC.
He received his undergraduate degree from Harvard College and a doctorate degree from the University of California, Berkeley.
David Cook active positions
| Companies | Position | Start |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Global HIV Vaccine Enterprise
 Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Director/Board Member | 2011-05-31 |
X-Biotix Therapeutics, Inc.
 X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Board Member | - |
Former positions of David Cook
| Companies | Position | End |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-02-28 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Chief Operating Officer | 2012-09-30 |
Bio Ventures for Global Health
 Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | Corporate Officer/Principal | 2010-01-31 |
| CERUS CORPORATION | Chief Tech/Sci/R&D Officer | 2007-10-31 |
Eligix, Inc.
 Eligix, Inc. Medical/Nursing ServicesHealth Services Develops and distributes medicines | Chief Tech/Sci/R&D Officer | 2001-07-31 |
Training of David Cook
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Develops and distributes medicines | Health Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Ventures for Global Health
Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | |
Anza Therapeutics, Inc.
 Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic vaccines for cancer and infectious diseases | Health Technology |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Commercial Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapeutics through the engineering of commensal gut microbes | Commercial Services |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Stock Market
- Insiders
- David Cook
